Expanded GAA repeats and clinical variation in Friedreich's ataxia
- PMID: 14653855
- DOI: 10.1034/j.1600-0404.2003.00190.x
Expanded GAA repeats and clinical variation in Friedreich's ataxia
Abstract
Introduction: One of the main features of Friedreich's ataxia (FA) is phenotypic variability that can now be explained by the molecular mechanism (GAA expansion) underlying the disease.
Materials and methods: We have analyzed genotype-phenotype correlations in a group of 40 patients homozygous for the GAA expansion.
Results: The smaller GAA expansion (GAA1 allele) size correlated with age at onset and progression disease rate, but we found no correlation between the larger GAA expansion (GAA2 allele) size and these clinical parameters. The frequency of pes cavus, scoliosis, axonal sensory neuropathy and areflexia increased with the size of GAA1, whereas some signs such as sphincter disturbances, cerebellar atrophy on MRI, amyotrophy, dysarthria and decreased vibration sense were associated with increased duration of the disease.
Conclusion: GAA1 size is the main determinant of FA phenotype and GAA2 size is a poor predictor of clinical variation. Some clinical features are independent of GAA1 and GAA2 sizes and are determined by the duration of the disease.
Similar articles
-
Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia.J Neurol. 2000 May;247(5):346-55. doi: 10.1007/s004150050601. J Neurol. 2000. PMID: 10896266
-
Friedreich's ataxia. Revision of the phenotype according to molecular genetics.Brain. 1997 Dec;120 ( Pt 12):2131-40. doi: 10.1093/brain/120.12.2131. Brain. 1997. PMID: 9448568
-
Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia.Mitochondrion. 2006 Apr;6(2):82-8. doi: 10.1016/j.mito.2006.01.005. Epub 2006 Apr 3. Mitochondrion. 2006. PMID: 16581313
-
Friedreich's ataxia: cardiac evaluation of 25 patients with clinical diagnosis and literature review.Arq Bras Cardiol. 2002 May;78(5):444-51. doi: 10.1590/s0066-782x2002000500002. Arq Bras Cardiol. 2002. PMID: 12045843 Review. English, Portuguese.
-
Friedreich's ataxia: clinical aspects and pathogenesis.Semin Neurol. 1999;19(3):311-21. doi: 10.1055/s-2008-1040847. Semin Neurol. 1999. PMID: 12194387 Review.
Cited by
-
Health-related quality of life and depressive symptoms in Friedreich ataxia.Qual Life Res. 2020 Feb;29(2):413-420. doi: 10.1007/s11136-019-02311-9. Epub 2019 Sep 28. Qual Life Res. 2020. PMID: 31564022
-
New and Emerging Drug and Gene Therapies for Friedreich Ataxia.CNS Drugs. 2024 Oct;38(10):791-805. doi: 10.1007/s40263-024-01113-z. Epub 2024 Aug 8. CNS Drugs. 2024. PMID: 39115603 Free PMC article. Review.
-
Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia.Arch Phys Med Rehabil. 2010 Jul;91(7):1044-50. doi: 10.1016/j.apmr.2010.04.007. Arch Phys Med Rehabil. 2010. PMID: 20599042 Free PMC article. Clinical Trial.
-
Variations of frataxin protein levels in normal individuals.Neurol Sci. 2011 Apr;32(2):327-30. doi: 10.1007/s10072-010-0326-1. Epub 2010 May 27. Neurol Sci. 2011. PMID: 20506029
-
Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort.Ann Clin Transl Neurol. 2021 Jun;8(6):1239-1250. doi: 10.1002/acn3.51352. Epub 2021 May 5. Ann Clin Transl Neurol. 2021. PMID: 33949801 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous